RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fortress Biotech - Stock

Fortress Biotech Market capitalization 2024

Fortress Biotech Market capitalization

13.87 M USD

Ticker

FBIO

ISIN

US34960Q1094

WKN

A14SJV

In 2024, Fortress Biotech's market cap stood at 13.87 M USD, a -78.86% increase from the 65.62 M USD market cap in the previous year.

The Fortress Biotech Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2030e725.517,97-
2029e721.758,02-
2028e680.148,51-
2027e199.9228,94-
2026e171.4933,74-
2025e128.4845,03-
2024e75.476,73-
202384.5168,45-
202275.7459,37-
202168.7953,37-
202045.668,00-
201936.6371,25-
201826.8877,23-
201717.2578,78-
201616.4895,21-
20150.866727,09-
2014---
2013---
2012---
2011---
2010---
2009---
2008---

Fortress Biotech Aktienanalyse

What does Fortress Biotech do?

Fortress Biotech Inc was founded in 2006 and is headquartered in New York City. The company specializes in the development of therapies for serious diseases and operates under a cooperative business model. The business model of Fortress Biotech is based on having multiple subsidiary companies under its umbrella, each focusing on specific development programs. This allows for specialized coverage of every aspect of the development process, from basic research to clinical trials to drug approval by authorities, by each subsidiary. Fortress Biotech has a total of nine subsidiary companies, each conducting its own research and development programs. These programs mainly target cancer, rare diseases, and metabolic disorders. With its various subsidiary companies, the company is able to develop and manufacture a wide range of therapeutic solutions. One of Fortress Biotech's most well-known subsidiary companies is Mustang Bio, a biotechnology company focusing on the development of immune-based therapies for cancer patients. The company has developed a promising CAR-T cell therapy that is currently being studied in clinical trials. Another subsidiary company of Fortress Biotech is Caelum Biosciences, which develops therapies for hematological diseases. The company is currently working on a promising monoclonal antibody therapy to help patients with the rare disease AL amyloidosis. In addition to its subsidiary companies, Fortress Biotech also collaborates with other companies and academic institutions to develop innovative therapies. The company has partnerships with companies such as Kadmon Holdings, Inc. and Aevi Genomic Medicine, Inc. Fortress Biotech has had an impressive growth story in recent years. Through targeted acquisitions of companies with promising product pipelines, the company has been able to rapidly progress and expand its offering of therapeutic solutions. In summary, Fortress Biotech is a promising biotechnology company specializing in the development of therapies for serious diseases. With its cooperative business model, wide range of subsidiary companies, and partnerships, the company is able to develop and bring innovative therapy solutions to market to help patients worldwide. Fortress Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Fortress Biotech's Market Capitalization

Fortress Biotech's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Fortress Biotech's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Fortress Biotech's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Fortress Biotech’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Fortress Biotech Stock

What is the current Fortress Biotech market capitalization?

The current market capitalization of Fortress Biotech is 13.87 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Fortress Biotech.

How has the market capitalization of Fortress Biotech developed in recent years?

The market capitalization of Fortress Biotech has increased/decreased by -78.86% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Fortress Biotech?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Fortress Biotech?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Fortress Biotech have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Fortress Biotech pay?

Over the past 12 months, Fortress Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fortress Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Fortress Biotech?

The current dividend yield of Fortress Biotech is .

When does Fortress Biotech pay dividends?

Fortress Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fortress Biotech?

Fortress Biotech paid dividends every year for the past 0 years.

What is the dividend of Fortress Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fortress Biotech located?

Fortress Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fortress Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fortress Biotech from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Fortress Biotech pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Fortress Biotech in the year 2023?

In the year 2023, Fortress Biotech distributed 0 USD as dividends.

In which currency does Fortress Biotech pay out the dividend?

The dividends of Fortress Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fortress Biotech

Our stock analysis for Fortress Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fortress Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.